| Mrs Myna Ruth Laughlin, ARNP | |
|
1705 N Washington Ave Ste C, Durant, OK 74701-2100 | |
| (580) 924-5439 | |
| (580) 366-5439 |
| Full Name | Mrs Myna Ruth Laughlin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 1705 N Washington Ave Ste C, Durant, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366515389 | NPI | - | NPPES |
| 530454 | Other | TX | TEXAS LICENSE |
| R0045593 | Other | OK | OK NURSING LICENSE |
| 200101720A | Medicaid | OK |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southeastern Pediatrics Pllc | 9335530419 | 2 |
News Archive
People who rate themselves as highly knowledgeable about a new infectious disease threat could also be more likely to believe they don't know enough, a new study suggests.
The measure would increase hospital outpatient rates, dramatically cut physician payments and link surgical center payment to quality.
A study by David Finkelhor, Ph.D., of the University of New Hampshire, and colleagues updates estimates and trends for childhood exposure to a range of violence, crime and abuse victimizations.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.
In the event of an influenza pandemic, the world's vaccine manufacturers will be in a race against time to forestall calamity.
› Verified 5 days ago
| Entity Name | Southeastern Pediatrics Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477210516 PECOS PAC ID: 9335530419 Enrollment ID: O20211228001046 |
News Archive
People who rate themselves as highly knowledgeable about a new infectious disease threat could also be more likely to believe they don't know enough, a new study suggests.
The measure would increase hospital outpatient rates, dramatically cut physician payments and link surgical center payment to quality.
A study by David Finkelhor, Ph.D., of the University of New Hampshire, and colleagues updates estimates and trends for childhood exposure to a range of violence, crime and abuse victimizations.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.
In the event of an influenza pandemic, the world's vaccine manufacturers will be in a race against time to forestall calamity.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Myna Ruth Laughlin, ARNP 135 Brandi Ln, Durant, OK 74701-7404 Ph: (580) 920-8504 | Mrs Myna Ruth Laughlin, ARNP 1705 N Washington Ave Ste C, Durant, OK 74701-2100 Ph: (580) 924-5439 |
News Archive
People who rate themselves as highly knowledgeable about a new infectious disease threat could also be more likely to believe they don't know enough, a new study suggests.
The measure would increase hospital outpatient rates, dramatically cut physician payments and link surgical center payment to quality.
A study by David Finkelhor, Ph.D., of the University of New Hampshire, and colleagues updates estimates and trends for childhood exposure to a range of violence, crime and abuse victimizations.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.
In the event of an influenza pandemic, the world's vaccine manufacturers will be in a race against time to forestall calamity.
› Verified 5 days ago
Darci Lynn Bowen, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1801 Chukka Hina, Durant, OK 74701 Phone: 580-920-2100 | |
Jodi Robinson, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1400 Bryan Dr, Suite 303, Durant, OK 74701 Phone: 580-931-2227 Fax: 580-931-2057 | |
Duncan Kovash, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1901 Chukka Hina, Durant, OK 74701 Phone: 580-920-2100 | |
Mrs. Jennifer Renee Nelson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1708 Delivery Lane, Durant, OK 74701 Phone: 580-924-5622 Fax: 580-745-5060 | |
Mrs. Johnette L Routh, A.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 Bryan Dr, #300, Durant, OK 74702 Phone: 580-924-1700 Fax: 580-924-1736 | |
Mrs. Jessica Laine Williams, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 Bryan Dr Ste 208, Durant, OK 74701 Phone: 580-920-9063 | |
Amanda Robertson, APRN, CNP, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2701 W University Blvd, Durant, OK 74701 Phone: 580-740-4053 |